Hemogenyx Pharmaceuticals PLC banner

Hemogenyx Pharmaceuticals PLC
LSE:HEMO

Watchlist Manager
Hemogenyx Pharmaceuticals PLC Logo
Hemogenyx Pharmaceuticals PLC
LSE:HEMO
Watchlist
Price: 1 102.5 GBX 2.08% Market Closed
Market Cap: £66.6m

Wall Street
Price Targets

HEMO Price Targets Summary
Hemogenyx Pharmaceuticals PLC

There are no price targets for HEMO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Hemogenyx Pharmaceuticals PLC Competitors:
Price Targets
ACIU
AC Immune SA
213% Upside
IPAR
Inter Parfums Inc
9% Upside
RLMD
Relmada Therapeutics Inc
100% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Revenue forecast
is not available for
Hemogenyx Pharmaceuticals PLC

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Operating Income forecast
is not available for
Hemogenyx Pharmaceuticals PLC

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Net Income forecast
is not available for
Hemogenyx Pharmaceuticals PLC
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HEMO's stock price target?
Not Available

HEMO doesn't have any price targets made by Wall Street professionals.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett